Importantly, our cell line data are highly consistent with the in vivo expression data of c-Myb, where high c-Myb expression occurs in slow growing, small-sized and lower grade human breast tumors, which tend to be highly responsive to hormone therapy. Here, MYB is linked to breast neoplasm.